The Sr. VP of Sales & Marketing of Corvel (NASDAQ: CRVL) is Selling SharesBy Carrie Williams
Based on Corvel’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $128 million and quarterly net profit of $6.95 million. In comparison, last year the company earned revenue of $124 million and had a net profit of $8.27 million. The company has a one year high of $53.19 and a one year low of $31.15. CRVL’s market cap is $657.4M and the company has a P/E ratio of 23.85.
The insider sentiment on Corvel has been neutral according to 30 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
CorVel Corp. provides medical cost containment and managed care services designed to address the escalating medical costs of worker’s compensation and auto claims. The company’s services are provided to insurance companies, third-party administrators, governmental entities, and self-administered employers to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It provides claims management, bill review, preferred provider networks, utilization management, claims management, case management, pharmacy services, directed care and medi-care services to these payers. CorVel Corp was founded by V. Clemons Gordon in 1987 and is headquartered in Irvine, CA.